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Ethical considerations in the marketing of e-health products
Ashish Chandra, Andrew Sikula, Sr., David P. Paul, III

Abstract The internet is now recognised as a growing international phenomenon. All kinds of
products and services are being marketed over the internet to consumers throughout the world
because country borders no longer restrict conducting business in the international marketplace.
Though there are several advantages of online commerce, this form of marketing does raise
ethical dilemmas, particularly when it comes to marketing healthcare products and information
to consumers internationally. This paper examines some of these potential ethical concerns and
provides some strategies for consumers and online pharmaceutical marketers to handle these
dilemmas more appropriately.

INTRODUCTION
New models of doing business blossomed in the 1990s with the rapid growth of the internet1 and
online trade has changed the way many businesses operate.2 Many businesses now feel
compelled to have some form of internet presence (eg ordering, order tracking, e-mail, a business
website), whether or not they actively use these tools to conduct business.3 This ‘internet mania’
is not surprising when one considers that 39 per cent of consumers logged onto the internet daily
in 2002, up 10 per cent over the previous year.4 Industries once widely considered as being
immune from the explosion in e-commerce are now quite rapidly incorporating the internet in
their business operations, including healthcare businesses. For example, rapid technological
advancements in the field of telecommunications are now also actively playing a significant role
in defining pharmaceutical and alternative health businesses. The changes we have already seen
and will continue to see, are not only in online pharmacy sales volume of traditional western
medicine, but also in the number of different types of alternative medicinal approaches and
products that are now being made available directly to consumers via the internet. Alternative
medicines, such as herbal products and homeopathic products, are not just a passing trend in the
US economy anymore. They are quite extensively and aggressively being marketed via the
internet.5
E-health refers to the convergence of various technologies such as the internet, computer
telephony/interactive voice response, wireless communications, plus direct access to healthcare
providers, healthcare management, healthcare education (perhaps via telemedicine) and wellness
information.6 Although many technologies are and will continue to be involved in the
development of e-health, the internet clearly has and will for the foreseeable future be the
primary driver for the growth in this field of healthcare, according to both clinicians7 and
consultants.8 Healthcare providers and consumers are more and more turning toward the

internet,9 which appears to have significantly enhanced the ‘reach’, ie the number of
unduplicated audience members who receive the promoted message, of many businesses,
including healthcare. Between 2000 and 2001, the number of Americans regularly searching
online for health information rose from 70 million10 to almost 100 million.11 Internet-based
healthcare will be worth US$370 billion by 2004.12
The internet has a tremendous potential of being of benefit to the healthcare consumer
and provider in the following ways:
•
•
•
•
•

By providing vast amounts of information regarding healthcare products and services in a
very convenient and rapid manner.13
By making available the latest healthcare research in a more timely manner as compared
with its appearing in nonelectronic print.14
By providing additional value-added services including cost savings for direct online
purchases by consumers.15
By providing therapy (or e-therapy) to consumers via the internet at the consumer’s
convenience.16
By providing both real-time and delayed consultation opportunities to practitioners and
patients in remote locations where healthcare practitioners, especially specialists, may be
few.17

While approximately 55 per cent of Americans view the internet as a reliable source of
healthcare information, compared with just under 30 per cent for newspapers and 28 per cent for
television,18 it has been estimated that over 50 per cent of the healthcare-related information on
the internet is not attributable to any authority and 7 per cent of the healthcare-related
information provided on the internet is false.19 Despite the lack of veriability of health-related
information on the internet, however, a Pew internet and American Life Project survey estimated
that 55 per cent of Americans with internet access have used the internet to gain health
information.20 The information technology revolution, as evidenced by the increasingly
widespread use of the internet, promises to cause a shift in the US healthcare system away from
the traditional delivery model.21 Unfortunately, despite the potential advantages of this shift for
both the healthcare consumer and provider and the apparent widespread use by Americans of this
approach for the gathering of healthcare information, the use of the internet may involve
significant ethical concerns. Some of these are discussed in the next section.

POTENTIAL ETHICAL DILEMMAS
Most basic to the continuing development of e-health is trust by all participants in the process.
Unfortunately, the security, use and distribution of patient data over the internet are significant
problems.22 Many patients fear that their privacy will not be respected and their health

information may be used to hurt them.23,24 For example, a survey conducted by CyberDialogue
showed that 75 per cent of individuals seeking health information on the internet were concerned
that the sites where they registered would share personal information with a third party without
their permission.25 A Harris Interactive study found that 58 per cent of respondents lacked
confidence in healthcare-related websites ability to protect personal information.26 There have
been numerous published accounts of confidential health information being shared with
unauthorised parties due to e-mail snafus.27
A growing sense of mistrust regarding healthcare websites actual content fuels the
development of internet healthcare ethical codes and standards.28,29 There are at least three
content-related concerns. First, all who rely on the internet for healthcare information must be
able to trust the reliability of the informational content obtained. Unfortunately, a survey
conducted by Harris Interactive showed that consumers have a relatively low level of trust in
websites sponsored by health insurers, hospitals and health plans.30 The same survey however,
indicated that most consumers would feel more confident in a healthcare website which
contained some kind of seal of approval or other indication of accreditation. Secondly, huge
amounts and variety of content increase the possibility of errors and/or misinterpretation.
Reliable, high quality content which is neither deceptive not misleading is mandatory if the ehealth industry is to gain users trust.31 Finally, as more and more people access the internet
seeking healthcare-related information, websites may be tempted to track these individual web
preferences, perhaps without their knowledge. Two techniques, one old and the other new,
should be mentioned here. ‘Cookies’ have been used for this purpose for years to track individual
internet movements by recording and reporting various websites visited. A newer approach
however, called ‘spyware’ has recently become available. Spyware inserts software into others
computer software which allows ‘carefully targeted advertising’.32 Patients may well be
concerned that such tracking methods used to craft advertisements to them could also be used to
track and collect other personal health information. Also, patients may feel that any healthcare
information they obtain from such websites is tainted by commercial motives,33 leading to a
further erosion of patient trust.
Complaints about biased website materials and lax confidentiality have prompted internet
healthcare participants to work with the healthcare community to develop both standards and
ethical codes to build public confidence in the system.34 Of course, self-regulatory codes of
ethics are often a tactical defence against legislative action by governments,35 but if done
properly (eg addressing all participant ethical concerns), can be quite effective and useful. Selfregulation may even be the preferred answer since legal control may not be practical. If
legislation does become enacted, organisations intent on continuing the prohibited practices can
easily move the website to another country and continue ‘business as usual’.36 Thus, the
healthcare ethics movement prefers a self-regulatory approach to protecting privacy and building
trust rather than a regulatory one.37
There are several ethical dilemmas pertaining to promoting pharmaceutical and other
healthcare products over the internet of which the consumer as well as healthcare professionals

should be aware. Transactions over a medium such as the internet, where transactions are no
longer any semblance of face-to-face, but instead are completely anonymous, may well ‘reduce
informal social controls that restrict fraud and may provide opportunities for product
misrepresentation’.38 Consumers should be concerned because they now have the ability to
access healthcare information independently of healthcare practitioners and with this
independent ability comes the associated requirement that consumers must independently
evaluate the healthcare information obtained.
Similarly, healthcare professionals should be concerned because they are responsible for
consumer health and wellness. Some of the more serious ethical concerns are discussed below.

Placement of unproven research on the Web
Healthcare research is constantly being conducted all over the world. Before the results of these
research activities become a widely acceptable reality and a viable product or protocol for
treating disease, research studies need to be published in reputable, peer-reviewed publications.
These publications need then to be widely circulated, mostly to the professional community, so
that the research results can be replicated by other physicians and scientists. Once the results
have been independently replicated by other researchers, they may be evaluated and possibly
accepted by the healthcare community and eventually utilised for the treatment of patients. The
internet however, provides a new avenue for researchers to publish their research, an avenue
which requires neither peer review nor replication. The consumer needs to be aware that the
information provided on many of these healthcare internet sites may not be in their best interest,
as the research placed on them may be providing only one researcher’s opinion/study in an
attempt to promote oneself as a ‘trend setter’.39,40 The average consumer is not qualified to
determine the difference between ‘legitimate’ scientific research and ‘questionable’ scientific
research and the Food and Drug Administration is concerned that misleading or unbalanced
promotional information may harm patients.41

Information on alternate medical therapy
Alternative forms of medication and treatment are available and practised worldwide, but
alternative medicine is more prevalent and most readily accepted by consumers in countries
other than the USA.42 In the USA, alternative medical products and treatments have gained
greater acceptance and demand for them has increased substantially over the past decade.43–45
This increased interest by consumers in alternative medicine may be attributed in large part to
the internet. But, this increased consumer interest also creates a major ethical dilemma for health
professionals. Most consumers do not know that alternative health products are often
regulated/classified as ‘food’ products. Food products do not go through the rigourous clinical
trials that traditional health products do. Hence, it is much easier for them to obtain marketing
clearance. In fact, many alternative health products are not even approved as ‘food’ products but

may be marketed directly to consumers as ‘natural’ products. Many such ‘natural’ products can
have serious adverse interactions with various prescription drugs. Health professionals may
advise against the use of various so-called ‘natural’ products when used in conjunction with
traditional therapies as they become aware of possible negative drug interactions due to the
simultaneous use of these different types of products. Many alternative products, however, which
are not available in the USA, can be acquired by the consumer from a foreign country via online
marketers. The dangerous part is that there may be no research available for the consumer or
even the health professional to make a calculated judgment regarding the potential hazards of
these product combinations.
Quality and cost issues
Given the availability of pharmaceutical products over the Web, serious concerns have been
raised regarding the quality of such products. The pharmaceutical industry is one of the most
lucrative industries in the world economy,46 and many companies want a piece of that lucrative
pie. Simply producing drugs is much cheaper without doing the research and development,
which are involved in the creation of these products. In 2001, the pharmaceutical industry as a
whole spent US$30 billion on research and development,47,48 with the average cost per drug
between US$400 and US$800 million.49,50 By definition, foreign pharmaceutical product
manufacturers are not bound by the stringent policies of the US Food and Drug Administration
and many countries also do not recognise the patent protection of US products. This opens a new
marketing avenue for foreign-based companies. Some foreign companies take advantage of the
lack of universal patent protection laws and manufacture their own version of popular brandname products. Since these companies have not spent a lot of money on conducting research and
development, they are able to bring products to the consumer at a significantly lower total cost
compared with brand-name products. These costs are cut even further when the pharmaceutical
products are made available directly to consumers over the internet via online companies,
because of the resulting lower advertising and distribution costs. The availability of these
products at a potentially much cheaper price than would be charged by traditional domestic
distribution channels has at times created a rift between consumers, health professionals and
retailers. Some may believe that health professionals are acting unethically when they suggest
that the consumer should purchase pharmaceutical products in the local retail market rather than
buying them over the internet. It may well be the case however, that the health professional is
actually more concerned about the consumer and more concerned about the quality of the
product than the cost of the product.

Similar drug names
One of the major problems that the healthcare industry has started to encounter over recent years
is the availability of pharmaceutical products that have names which are quite similar, but they
are intended to treat different health conditions. The major unethical situation that the internet

can pose is that unethical companies may market their products using names similar to popular
brand-name products. Consumers are often not aware of the correct spelling of a brand-name
product; they are only aware of how the drug name is pronounced or sounds. This potential
problem makes customers vulnerable to the unethical marketing practices of questionable online
pharmaceutical product marketers. Consumers may risk losing not only their money, but also
their health and even their lives.

Litigation problems
If there is a serious adverse event that is a direct result of unethical marketing practices of online
pharmaceutical companies, which are based in a foreign country, it will be extremely difficult for
a consumer to file a lawsuit against the perpetrator. The internet is so new that many countries
have very few laws that regulate this industry. Unethical online pharmaceutical marketers may
take advantage of this shortcoming and unsuspecting consumers. In some instances, it may even
be hard for brand-name pharmaceutical product manufacturers to win a lawsuit against unethical
marketers and manufacturers and prevent them from supplying questionable products directly to
consumers. The advent of internet technology has been so rapid that legal systems governing the
trade of goods and services in the domestic and the international markets have not been able to
keep abreast of potential problems. Therefore, online pharmacies should be aware of the fact that
they will soon be seeing some changes in legal systems that may affect their business
operations.51 Whether these changes will help or harm the success of online pharmacies can only
be determined in the future.
Language concerns
The vast majority of websites worldwide are written in English. The English that is spoken and
written in different parts of the world however, varies significantly. There may be several ethical
online pharmaceutical marketers that provide information to consumers in English that is only
locally understandable. This may be understood in a different way, by consumers in different
parts of the world, who also will have access to the websites of ethical marketers. Suddenly, an
unintentional, unethical dilemma may be generated to which consumers become exposed. Hence,
it is advisable that marketers use the most basic and simple English, which can cause the least
amount of cross-cultural confusion.
Believability of the information
One of the most dangerous situations being caused by the internet, particularly as it relates to
healthcare, deals with information believability and acceptability by consumers. Consumers
often tend to believe what they perceive is in their best interest. Sometimes the information
provided by the health professional to the patient may not be what the patient desires to hear, but
it is accurate. Under such circumstances, a consumer may seek alternate sources of information

to obtain a more desirable answer. Unfortunately, there are several marketers who are planning
and hoping for this consumer shortcoming. Marketers may place highly desirable information on
the internet and then hope that consumers will purchase the products which are strategically
posted on the website. There are several online alternative product marketers who are using such
strategy. At times, one wonders whether there is any disease state that some of these online
marketers cannot treat or will not exploit.
Consumer education regarding scientific information
Healthcare professionals insist that patients lack sufficient education and training in
pharmacology and therapeutics to adequately understand much of the healthcare information
made available to them, let alone its implications.52 For example, about one-third of consumers
feel that the product information provided in direct-to-consumer (DTC) advertisements for
prescription pharmaceutical products is too difficult to understand,53 and only one-third of
consumers even claim to read all or most of the brief summary, or the detailed information
provided in DTC ads.54 Thus, the argument can certainly be made that providing health
information and/or products directly to consumers over the internet could be extremely
detrimental to the consumer’s wellness and also to his/her faith and belief in the healthcare
system. It could also ignite a hypochondriac .re in consumers, as they may start believing that
they suffer from each and every side effect related to product use as mentioned in the website.
While this type of problem could also occur when a patient is prescribed and is taking a
prescription drug, it is much less likely to occur, for two reasons. First, with prescription drugs,
package inserts and/or information sheets are provided to consumers at the pharmacy or doctor’s
office, which might well not occur with an online purchase. Secondly, with a face-to-face
transaction, a healthcare professional is always available to address any questions or concerns
expressed by a patient. With the consumer purchasing healthcare products via the internet, there
could be no possibility of a consultation between the consumer and a healthcare professional
before the product purchase decision is made. Potentially, this lack of consultation opportunity
with internet purchases could affect the consumer purchasing decision regarding legitimate
products.
Lack of accompanying documentation
The online pharmacies based in international countries are not obligated to provide
documentation, such as patient package inserts, to consumers. In an investigative study by
Fischman and Melton, several pharmaceutical products were acquired from online pharmacies.55
Many of these products were shipped from foreign countries, including the UK, Spain and
Thailand. Some products, which were shipped from some foreign countries, came with no
documentation and also in mislabelled envelopes. This raises concerns regarding the ethical
standards of some online pharmacies.

SUMMARY GUIDELINES FOR ETHICAL ONLINE HEALTHCARE MARKETERS
The following is a list of some steps that ethical online marketers can take in order to reduce
consumer concerns regarding the reliability of such organisations.
•

•

•

•

•

•

Provide real names and the physical address/location for online pharmacies and other
healthcare companies. Aliases for names and post office addresses may tend to raise red
flags regarding the legitimacy of an organisation.
Provide the ‘technical’ information in layman terms. Use appropriate word processing
software to determine the desired readability needed to understand the information. One
should keep in mind that the recommended reading level for healthcare consumers is
fifth-to-seventh
grade.56
Avoid using scientific jargon. Most individuals accessing the website would certainly be
predominately lay people who would not be expected to understand formal healthcare
terminology.
Avoid having automatic links to other websites popping up in the consumer’s computer
when they are accessing your website. This irritating and intrusive approach57–59 can
create a detrimental impression in the consumer’s mind that this website is more
interested in its own revenues than providing quality health to consumers.
Provide references where the consumer can go to find more information about a website.
The website should in fact encourage consumers to check with references to ensure that
ethical standards are maintained by this website.
Prominently display the organisation’s compliance with an accepted Code of Ethics, such
as Health Internet Ethics or HiEthics,60,61 on the website home page. An ethics code can
reassure consumers regarding the ethical nature of a website.
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